Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of PRP in Periorbital Hyperpigmentation
NCT03114514Completed
- Sponsor
- Damascus University
- Start
- Jun 2016
- Primary completion
- Apr 2017
- Modality
- Adoptive Cell Transfer
- Countries
- 1
01
Overview
Open-label, single-arm trial of platelet-rich plasma injection in periorbital hyperpigmentation (POH), sponsored by Damascus University. Primary endpoint: Change in Skin Color. Started Jun 2016; status: completed.
02
Drugs
platelet-rich plasma injection
03
Conditions
periorbital hyperpigmentation (POH)
Beyond the preview
Go deeper on NCT03114514.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03114514.